| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K16147474 |
| PharmacoGx | BRD-K16147474 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RFX3 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.07 |
| mRNA | KCTD20 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.07 |
| mRNA | ADCY1 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.07 |
| mRNA | C1orf226 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.07 |
| mRNA | GGT2 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.07 |
| mRNA | USP31 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.07 |
| mRNA | CCDC136 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.07 |
| mRNA | RBM14 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.07 |
| mRNA | PSMD1 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.07 |
| mRNA | CHCHD1 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.07 |
